Haematological Malignancies 2011 brings together leading experts in the fields of haematology, oncology and transplantation to discuss the central issues and current challenges facing the management and treatment of patients with leukaemia, lymphoma and myeloma. Benefits of attending Haematological Malignancies 2011: • Hear comprehensive overviews of current and novel diagnostic and prognostic markers for the haematological malignancies • Examine current strategies for the treatment of acute and chronic leukaemia, lymphoma and myeloma • Gain insights into optimising patient care, including improving palliative care provision and ensuring effective communication between other specialists for expansion of treatment possibilities • Take part in the interactive case study sessions on optimal management of acute and chronic leukaemia, myeloma and Hodgkin’s lymphoma, discussed by panels of multidisciplinary experts • Share and exchange ideas with the leading practitioners in the field